Prosecution Insights
Last updated: July 17, 2026
Application No. 17/903,336

STERILIZATION APPARATUS FOR VEHICLE AND STERILIZATION SYSTEM FOR VEHICLE INCLUDING THE SAME

Non-Final OA §102§103
Filed
Sep 06, 2022
Priority
Jun 08, 2022 — RE 10-2022-0069497
Examiner
DOWNES, NATHANAEL JASON
Art Unit
1794
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Hyundai Mobis Co., Ltd.
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
15 granted / 24 resolved
-2.5% vs TC avg
Strong +28% interview lift
Without
With
+27.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
18 currently pending
Career history
49
Total Applications
across all art units

Statute-Specific Performance

§103
89.3%
+49.3% vs TC avg
§102
9.2%
-30.8% vs TC avg
§112
1.5%
-38.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 24 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kohring (US2022008598A1). Regarding Claim 1, Kohring teaches a decontamination system (#100) comprising a cartridge (#110) contains an antibacterial solution (which sterilizes surfaces see [para. 0010]) which is placed in a housing (#140) that is located inside a vehicle dashboard vent system [0025]. Further, the apparatus is operated using a switch (#210) which powers the system to ON [0032]. It is understood that a switch is an electromechanical element which functions as a drive source. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2 is rejected under 35 U.S.C. 103 as being unpatentable over Kohring (US20220008598A1), as applied to claim 1 above, and further in view of Van den bossche (US20120189490A1). Regarding Claim 2, Kohring teaches to claim 1 as shown above. Kohring further teaches that the antibacterial and antiviral sterilizing solution (#115) is vaporized into a mist and transported through the housing into the centra pipe of the vehicle vent [0026]. However, Kohring does not teach that a first sterilizing part is configured to generate ozone. Van den bossche teaches a process for cleansing and deodorizing a space [abstract]. Van den bossche teaches a system for treating a space with ozone, which has the advantage of sterilizing the space [0006] wherein the apparatus is capable of producing sufficient ozone to cleanse a volume comparable to an automobile [0079]. Van den bossche teaches an apparatus which comprises at least an ozone-generating unit (#200, Fig. 2) and a liquid nebulizing unit (#300, Fig. 2) [0078]. Van den bossche teaches that using a nebulized cleanser (understood to be an equivalent of sterilizer) in tandem with an ozone treatment allows for the treated surface to be more resistant to new microbial growth [0072]. Prior to the filing of the present invention, it would have been obvious to one of ordinary skill in the art that the base device of a sterilizing apparatus featuring nebulized sterilizing solution, as per Kohring, could incorporate the process of adding a preceding or following step of providing ozone by means of an ozone-generating unit with a reasonable expectation of success to arrive at a sterilizing apparatus connected to an automobile vent that sterilizes the vehicle cabin such that the space would be more resistant to microbial growth. Allowable Subject Matter Claims 3-9 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The prior art does not teach or suggest a sterilizing apparatus in connection with a vent of a vehicle that requires a “rotation part” which includes a rotator with a plurality of chambers in which are located the first and second sterilization units, wherein the rotator is in connection to the drive source. While it is known in the art to have a nebulizing sterilizing spray and an ozone-generator, it is known to place this components together in a rotating structure. Claims 10-20 are allowed. The following is an examiner’s statement of reasons for allowance: The prior art does not teach or suggest a sterilizing apparatus in connection with a vent of a vehicle that requires a “rotation part” which includes a rotator with a plurality of chambers in which are located the first and second sterilization units, wherein the rotator is in connection to the drive source. While it is known in the art to have a nebulizing sterilizing spray and an ozone-generator, it is known to place this components together in a rotating structure. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NATHANAEL J DOWNES whose telephone number is (571)272-1141. The examiner can normally be reached 8am to 5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James Lin can be reached at (571) 272-8902. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. NATHANAEL JASON. DOWNES Examiner Art Unit 1794 /NATHANAEL JASON DOWNES/Examiner, Art Unit 1794 /BRIAN W COHEN/Primary Examiner, Art Unit 1759
Read full office action

Prosecution Timeline

Sep 06, 2022
Application Filed
May 06, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678525
Microwave-Plasma Disinfector (Origreen)
4y 0m to grant Granted Jul 14, 2026
Patent 12668487
SOLAR PRODUCTION OF HYDROGEN USING DEFECT ENGINEERED BORON-RICH PHOTOCALYSTS
3y 11m to grant Granted Jun 30, 2026
Patent 12656003
AIR PURIFYING SYSTEM
4y 3m to grant Granted Jun 16, 2026
Patent 12643093
NICKEL-BASED MOF FILM PHOTOCATALYST GROWN IN-SITU ON FOAMED NICKEL SURFACE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
3y 9m to grant Granted Jun 02, 2026
Patent 12618168
METHOD FOR SURFACE TREATMENT AND/OR PRODUCTION OF A MEDICAL PRODUCT, AND A MEDICAL PRODUCT
3y 7m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
90%
With Interview (+27.8%)
3y 7m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 24 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month